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Coronary Artery Disease? A Clinical-Morphologic Assessment 
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Although various public health preventive efforts and pre- 
scribed pharmacologic treatment methods will have long- 
term benefits in the reduction of coronary artery athero- 
sclerosis and subsequent cardiac events, the immediate and 
short-term future in the treatment of coronary artery 
disease will focus on several interventional devices designed 
to remodel or remove causes of acute and chronic coronary 
artery obstruction. Certain clinical-morphologic aspects of 
these interventional devices or techniques that result in 
remodeling of the coronary lumen shape (balloon angio- 
plasty. thermal probes, intravascular stents) or removal of 
obstructing material (lasers, atherectomy devices) are re- 
viewed. Two new areas in the pathology of atherosclerotic 
plaque (plaque fissures, eccentric plaque) and their clinical 
relevance in coronary heart disease are described. 
(J Am Co11 Cardiol 1989;13:969-87) 
During the last 10 to I5 years, we have seen the development 
and continued evolution of various pharmacologic and me- 
chanical forms of therapy used in the treatment of athero- 
sclerotic coronary artery disease. Despite significant de- 
of atherosclerotic coronary artery disease, and will describe 
two new concepts in coronary morphology that will have 
future impact on treatment modalities. 
Many techniques and devices (dilating balloons, perfusion 
clines in the last 25 years, atherosclerotic balloons, thermal probes and balloons, lasers, 
coronary artery disease remains the leading 
;li :C: .C: 
atherectomy devices, stents) have been used or 
cause of death in the United States. Significant ?? = ?? - + * ?? - * 9 
advances have been made in the area of preven- : : * 
tion with large scale public education efforts , 
showing the relation between various “risk fat- 
tars” and the development of coronary athero- ‘0 1 
are under study for future use. These techniques 
?? ??th and devices can be separated into two main 
‘ . categories based on their effects on coronary 
sW . luminal shape or obstruction: wmodeling 
(“cracking,” “breaking,” “stretching,” 
sclerosis. Recent human studies (l-3) have dem- A N N , v E R s A R y “welding”) and rrr~lo~~~i (“scraping,” 
onstrated angiographic regression of coronary 
1949-1989 
“shaving.” “burning.” “melting”). 
atherosclerosis after various lipid-lowering ther- 
apies. Despite promising efforts in these aFeas. altering daily 
habits and risk factors and the use of pharmacologic therapy 
take several year:, to decades to accomplish results. Al- 
though the future treatment of atherosclerotic coronary 
disease lies in prevention, the immediate future of therapy 
will focus on the use of various intervention techniques and 
devices. This review will examine clinical-morphologic as- 
pects of several of the currently used and developing inter- 
ventional techniques and devices employed in the treatment 
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This urticlc is part ofu series of‘urticles celebrating 
the 40th anni\~ersury of the American College oj 
Cardiology. The series attempts to set the stage for the 
jirtrrrc by drscrihing current state oj’ the art munuge- 
ment of selected mujor cardiovascular problems and 
thr basic knonYedge that will providr directions for 
udlwnces in diugnosis und therapy. 
Remodeling Techniques 
Various techniques and devices have been developed that 
in effect alter the degree of coronary lumen shape or amount 
of obstruction by “displmcing” plaque or thrombus, or both, 
“c~~rcking” or “hrecrking” plaque. “stwtc‘hing” a portion or 
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all of the vessel wall to enlarge the lumen or “welding” 
portions of the obstructing material against adjacent walls. 
All of these methods attempt to increase luminal cross- 
sectional area and improve blood flow. 
Coronary Balloon Angioplusty 
Since its introduction in 1977 (4), coronary balloon angio- 
plasty has gained wide acceptance as a nonsurgical form of 
therapy for acutely and chronically obstructed vessels. In- 
creased experience and advances in technology have re- 
sulted in an increased primary success rate (90% to 95%) and 
lowered complication rate (4% to 5%) (5). Despite the 
therapeutic success of coronary balloon angioplasty, the 
exact mechanism or mechanisms by which balloon angio- 
plasty improves vessel patency remains unsettled. Morpho- 
logic and histologic observations in coronary arteries of 
patients undergoing percutaneous transluminal balloon 
angioplasty are limited (619), but provide us with clues 
regarding the mechanism of action. These observations may 
be divided into two categories: 1) changes observed early 
(acute) (530 days) after balloon angioplasty, and 2) changes 
observed late (chronic) (>30 days) after balloon angioplasty. 
Early (Acute) Changes 
Morphologic changes. Morphologic changes in coronary 
arteries 530 days after dilation have been reported by 
several investigators (6,8-10,l l-15,17,18). Block et al. (6) 
initially described “splitting” of atherosclerotic plaque in 
two patients undergoing balloon angioplasty. In one patient, 
an extension of the plaque “splitting” into the coronary 
media resulted in a dissecting hematoma. We (9,18) subse- 
quently reported morphologic and histologic observations in 
several patients undergoing angioplasty procedures 4 h to 30 
days before tissue examination. In each patient, an intimal 
“crack, ” “tear, ” “fracture” or “break” was recognized, 
and each had variable degrees of medial penetration. In 
some patients, the medial involvement was localized (barely 
penetrating the internal elastic membrane) (Fig. l), and in 
others, it was extensive (dissection anterograde, retrograde 
or both); adventitial disruption was not observed. We (17) 
reported nine additional necropsy patients who had under- 
gone a balloon angioplasty procedure alone or in conjunction 
with a thrombolytic agent in the treatment of evolving acute 
myocardial infarction. Each of these nine patients had in- 
timal-medial tears, but four patients with combined throm- 
bolytic reperfusion and balloon angioplasty had associated 
coronary wall and lumen hemorrhage (Fig. 2). Mizuno et al. 
(12) serially sectioned the balloon angioplasty site in one 
necropsy patient, and observed intimal and medial splitting 
that led to coronary artery dissection. Soward et al. (14) 
reported plaque splitting, medial dissection and “lifting” of 
the atherosclerotic plaque from the medial 
Figure 1. Localized coronary artery dissection (arrows) is present at 
the site of transluminal balloon angioplasty in the left anterior 
descending (LAD) coronary artery. LM = left main. From Wailer 
(8), with permission of the publisher. 
layer at the site of previous balloon angioplasty. La Delia et 
al. (19) recently reported histologic findings in the left 
anterior descending coronary artery of a patient receiving 
angioplasty and streptokinase for an evolving acute myocar- 
dial infarction. Atherosclerotic plaque “cleavage,” subin- 
timal leukocytic infiltrations and medial and adventitial 
fractures with hemorrhage were observed. 
Late (Chronic) Changes 
Although minimal early morphologic information is avail- 
able from the coronary arteries of patients undergoing bal- 
loon angioplasty, even less morphologic information is avail- 
able late (>30 days) after the procedure (1,18,20-23). To 
date, late changes observed in human coronary arteries after 
angioplasty may be divided into two categories: 1) ~to 
morphologic evidence of previous angioplasty injury (Fig. 
3), and 2) intimalfibrous proliferation (Fig. 4). 
No morphologic evidence of previous balloon angioplasty 
injury. We (8,10,13) reported morphologic-histologic 
changes at the site of angioplasty in three men who died 
suddenly 80, 90 and 150 days, respectively, after clinically 
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Figure 2. Thromblytic therapy with streptokinase com- 
bined with balloon angioplasty. Coronary artery site of 
angioplasty (A) showing marked adventitial hemorrhage 
(B). Numbers in B indicate sites of cross sections (1 to 3) 
shown below. 1, Prominent atherosclerotic plaque 
“crack” with surrounding hemorrhage. 2 and 3, Marked 
bleeding into the area of angioplasty severely narrows 
the coronary lumen. LAD = left anterior descending 
artery; LC = left circumflex artery; LM = left main 
artery; R = right coronary artery. From Waller et al. 
(17). 
successful coronary angioplasty. In all three the left anterior 
descending coronary artery had increased angiographic lu- 
rninal diameter and decreased transstenotic pressure gradi- 
ent, and each patient had relief of angina pectoris and 
improved exercise tolerance. Of the two clinically asympto- 
matic patients, one died suddenly at home (sudden coronary 
death) and the other was killed in an automobile accident 
while intoxicated with alcohol (noncardiac cause of death). 
The symptomatic patient died suddenly at work (sudden 
coronary death). At necropsy. the site of balloon angioplasty 
in the left anterior descending coronary artery in each 
patient was narrowed 76% to 95% in cross-sectional area by 
fibrous atherosclerotic plaques (Fig. 3). Each balloon angio- 
plasty site was free of intraluminal thrombus and mural 
hemorrhage. Histologic assessment of atherosclerotic 
plaque in the areas of previous angioplasty compared with 
other areas of atherosclerotic plaque in the same artery or 
other arteries in the same patient disclosed no distinctive 
morphologic differences. No distinctive acute morphologic 
lesions or healed modifications of these lesions were recog- 
nized late in these three patients. 
Intimal fibrous proliferation. Essed et al. (7) were the first 
to report finding, 5 months before death, intimal fibrous 
hyperplasia at the site of coronary angioplasty. Cross sec- 
tions of the left anterior descending coronary artery showed 
evidence of previous disruption of the media, with extensive 
proximal and distal coronary dissection. A large intimal 
“crack” with a partial “flap” formation created a “false 
channel.” After 5 months, the fibrocellular proliferation 
“coated” surrounding portions of atherosclerotic plaque in 
addition to the area of previous plaque fracture, producing a 
severely narrowed coronary artery. Austin et al. (IS) ob- 
served a late angioplasty site that appeared to have distinct 
intimal layers: an outer layer composed of hypocellular 
connective tissue with cholesterol clefts (atherosclerotic 
plaque), and an inner layer composed of smooth muscle 
cells, fibroblasts and a basophilic interstitial matrix (intimal 
fibrous proliferation). The outer atherosclerotic plaque layer 
contained “gaps” that were presumed to be evidence of the 
previous balloon angioplasty; these “gaps” were filled with 
the cellular proliferation of the inner layer. We (16) recently 
reported histologic evidence of restenosis in the proximal 
left anterior descending coronary artery 4 months after a 
clinically successful angioplasty (Fig. 4). The site of previous 
balloon angioplasty had evidence of atherosclerotic plaque 
“cracks” or “splits” and localized medial dissection (dis- 
ruption) similar to lesions observed in patients who died 
acutely after balloon angioplasty. The initial underlying 
atherosclerotic plaque was still clearly identified, and the 
luminal channels created by the angioplasty procedure 123 
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Figure 3. Histologic cross section of the left anterior descending 
coronary artery at the site of transluminal balloon angioplasty 150 
days before sudden death, showing severe luminal narrowing by 
atherosclerotic plaque. From Waller (lo), with permission of the 
publisher. 
days earlier were filled with fibrocellular tissue that coated 
the denuded media and narrowed the coronary lumen 96% to 
100% in cross-sectional area. Fibrocellular tissue prolifera- 
tion involved 28 mm of the proximal left anterior descending 
artery and then abruptly disappeared, covering a distance 
corresponding to the lengths of the previously used angio- 
plasty balloons. 
Thus, in the angioplasty sites seen late after angiographi- 
tally successful balloon angioplasty, no distinctive lesion or 
I 
lesions may seen or, more commonly, a concentric fibrocel- 
lular proliferation is observed, which is distinctly different 
from underlying atherosclerotic plaque. The absence of 
morphologic signs of previous angioplasty in the former 
should not be interpreted as indicating “acceleration of 
underlying atherosclerotic plaque” in a mere 80, 90 or 150 
days (8,lO). 
I 
Mechanism(s) of Balloon Angioplasty 
Plaque compression. Dotter and Judkins (24) in their 
original description of the angioplasty procedure (as well as 
Gruentzig [25] 12 years later) initially attributed the mecha- 
nism of balloon angioplasty to redistribution and compres- 
sion of intimal atherosclerotic plaque (Fig. 5). Inflation of the 
angioplasty balloon within an arterial stenosis was thought to 
“compress” atherosclerotic plaque components against the 
arterial wall, thereby resulting in a larger vessel lumen. 
However, the vast majority of atherosclerotic plaque in 
human coronary arteries is composed of dense fibrocollage- 
nous tissue with varying amounts of calcific deposits and 
much smaller amounts of intracellular and extracellular lipid 
(that is, “hard plaques”). Thus, it appears unlikely that 
plaque compression plays a major role in human coronary 
artery balloon angioplasty dilation. In experimental animal 
models, vessel-induced injury plus a high cholesterol diet are 
used to create atherosclerotic lesions. The atherosclerotic 
lesions induced in these models are composed almost en- 
Figure 4. Intimal fibrous proliferation 
(IPF) of the left anterior descending artery 
“coating” underlying atherosclerotic 
plaque (AP) 4.5 months after balloon 
angioplasty. L = lumen. From Waller (16). 
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“Compression” of plaque 
Focal plaque “break”. (8) 
minimal plaque compression 
“fracture” or “tear” 
“a (e-2 
“Stretching” of plaque-free 
wall segment in 
eccentric lesion 
Focal plaque “break”, 
“fracture” or “tear” 
with localized dissection (D) 
Figure 5. Diagram of five possible mechanisms of coronary artery 
balloon angioplasty. .40 = aorta; LAD = left anterior descending 
artery; LC = left circumflex artery: LM = left main coronary artery. 
From Wailer (34). 
tirely of lipid-laden foam cells without dense collagen and 
calcific deposits (that is. “soft plaques”) and may be sus- 
ceptible to compression. 
Plaque fracture. Data from angioplasty results in exper- 
imental models (26-28). human necropsy coronary arteries 
(29-31) and human vessels examined after successful or 
complicated angioplasty procedures (6,12,14) suggest that 
the major mechanism of human coronary angioplasty is 
“breaking,” “cracking.” “ splitting” or “fracturing” of ath- 
erosclerotic plaque (Fig. 5). Plaque fractures, breaks (also 
called dissection clefts) and cracks extending from the lumen 
for variable lengths into the plaque provide a means of 
improving vessel patency by creating additional channels or 
avenues for coronary blood flow. Healing and repair changes 
at the angioplasty site eventually may remodel the acute 
pathologic lesions or lesions to alter or eliminate their distinc- 
tive features described previously. The healing process at the 
angioplasty site itself also may increase (as has been noted 
angiographically [32]) or decrease luminal size (restenosis). 
Plaque fracture, intimal flaps and localized medial dissec- 
tion. Wailer et al. (9) reported plaque fracture, “intimal 
atherosclerotic flaps” and “localized media1 dissection” as 
the major mechanism of balloon angioplasty in human cor- 
onary arteries from patients undergoing angioplasty during 
life (Fig. 5). Initial and persistent luminal cross-sectional 
area expansion appears to require deep intimal fractures 
(occasionally creating intimal “flaps”) with localized tears 
or dissection of the underlying media. Failure to obtain 
localized and limited medial involvement in addition to the 
intimal cracks may be a cause of early “restenosis” after an 
initially successful dilation. 
Stretching of plaque-free wall segment. An additional 
mechanism of coronary artery dilation appears to be 
“stretching” of plaque-free wall segments of eccentric ath- 
erosclerotic lesions (Fig. 5) (33-35). Inflation of an angio- 
plasty balloon across eccentric plaque lesions may distend or 
stretch the normal wall segment and produce little or no 
damage to the plaque on the remaining portions of the 
arterial wall. Stretching of the plaque-free wall segment may 
result initially in an increase in coronary lumen diameter and 
cross-sectional area, but several weeks later gradual relax- 
ation of this overstretched segment (“restitution of tone”) 
decreases the coronary lumen toward the predilation state. 
This decrease may provide another explanation for early 
restenosis after an initially angiographically successful dila- 
tion (34.35). The high frequency of an eccentric type of 
coronary lumen in severely diseased vessels (35-37) suggests 
that stretching of the plaque-free wall segment may be a 
more frequent mechanism of clinically successful coronary 
angioplasty than previously thought. 
Stretching and compression. A fifth mechanism for bal- 
loon angioplasty of coronary arteries is the combination of 
vessel stretching with minimal or mild plaque compression 
(Fig. 5). In this situation. an oversized angioplasty balloon 
may stretch the entire coronary segment that is concentri- 
cally narrowed by fibrocollagenous plaque. 
Although the technique of hulloon angiopiasty has been 
high1.v suu~essjirl, the procedure has been plagued with two 
mujor problems crt the site of angioplnsty: I) curly (uhrupt) 
cioslrre (Fig. 6). und 2) lute closure ~“reLstenosis”) (Fig. 7). 
Various new interventional devices and techniques have 
been used to attempt to solve these problems. 
Acute (Abrupt) Closure of the Angioplasty Site 
Mechanisms for abrupt closure (Fig. 6). Despite improve- 
ment in equipment and technique, abrupt closure at the 
angioplasty site occurs in 2% to 6% of patients treated with 
balloon angioplasty (38-42). Clinical explanations for the 
abrupt closure include coronary artery spasm (2%), localized 
thrombus (8%) and coronary dissection (34%) (42). Morpho- 
logic explanations for abrupt closure of the angioplasty site 
are depicted in Figure 6. Acute vessel occlusion from a 
folded, curled-up, large intimal flap accounts for the vast 
majority of these cases (Fig. 6a). This morphologic finding 
may correspond to the clinical category of “dissection” in 
that a large intimal flap is created by an extensive intimal- 
medial dissection plane. Acute closure may be produced by 
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Intimal-medial 
flap(s) f thrombus 
Stretching of 
plaque-free wall 
segment-spasm 
hrombu 
Subintimal 
Figure 6. Diagram showing causes of acute or 
lintraplaque) early luminal narrowing or closure (“restenosis”) 
bleeding of the percutaneous transluminal coronary balloon 
B’ood &.T\ 
(=~_~ angioplasty (PTCA) site. 
PTCA + acute 
thrombolytic agent 
(luminal bleeding) 
Endothelial injury 
with acute 
fibrin-platelet thrombus 
lntimsl fibrous 
proliferation 
Stretching of 
plaque-free 
wall segment 
in eccentric lesion 
Gradual return of 
stretched free wall 
to pro-PTCA shape 
Figure 7. Diagram showing causes of 
late luminal narrowing or closure 
(“restenosis”) of the percutaneous 
transluminal coronary balloon angio- 
p,a ty(PTCA) site. 
Minimal stretching of Return to original 
fibrous plaque to non- state of critical 
critical luminal narrowing luminal narrowing 
Progression of 
atherosclerotic disease 
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Figure 8. Cross section of endarterectomy specimen from a coro- 
nary artery undergoing balloon angioplasty, showing extensive 
plaque hemorrhage and luminal (L) thrombus (T). From Wailer (8). 
with permission of the publisher. 
abrupt reluxation of an overstretched diseuse-free wall of an 
eccentric plaque (Fig. 6b). The coronary artery media of the 
disease-free wall contains smooth muscle, and is capable of 
“reacting” to various humoral, neurogenic or traumatic 
(balloon dilation) stimuli. This morphologic mechanism may 
correspond to the clinical category of spasm. The potential 
for dynamic alteration of the coronary lumen (wall spasm) is 
more likely to occur with eccentric than with concentric 
atherosclerotic lesions (35). 
Nonocclusive fibrin-platelet thrombus frequently layers 
the angioplasty site, but occlusive thrombus at the site of 
balloon angioplasty is an uncommon finding in patients who 
die within hours of coronary dilation (Fig. 6c) (8.10,13). 
Although thrombus may be associated with large, curled-up 
intimal flaps, the primary mechanism for abrupt closure is 
the intimal-media1 flap. Subintimal hemorrhage from trau- 
matic balloon injury of atherosclerotic plaque is a possible 
cause for abrupt closure. Subintimal plaque bleeding may 
acutely expand the plaque and severely narrow or occlude 
the angioplasty site (Fig. 6d and 8). Intraplaque and intralu- 
minal bleeding can acutely occlude an angioplasty site (Fig. 
2 and 6e), but has been reported (17) only in the setting of 
combined balloon angioplasty and thrombolytic therapy. 
Treatment of abrupt closure (Fig. 9 and 10). Treatment of 
sites of abrupt closure has included repeated balloon angio- 
plasty and prolonged (30 to 60 min) balloon inflation with the 
use of perfusion catheters (“bailout catheters,” hemoperfu- 
sion catheters, autoperfusion catheters, shunt catheters [43- 
481). Perfusion catheters are placed across the occluded 
angioplasty site so that arterial blood enters the catheter 
proximally and exists distally (Fig. 9). 
Newer devices also may have an important role in the 
treutment of abrupt closure sites (Fig. 10). Large intimal 
flaps may be “sealed” or “welded” against the adjacent 
vessel wall with the use of thermul angioplusty balloons 
(Fig. lob). “Pyroplasty” techniques (“thermal welding”) 
may employ laser or radiofrequency energy sources 
(20,2 I ,49-53). An advantage of pyroplasty techniques over 
perfusion catheters is the immediate repair of the intimal- 
medial flap without the need for coronary artery bypass 
grafting. 
Balloon-e,~prpclndable intravascular stents (an intravascu- 
lar mechanical support device) have also been used for 
abrupt closure of an angioplasty site (Fig. 10d) (23.54-60). 
Several types of these metal meshwork devices are being 
tested. and at least one has been used in the coronary 
arteries for the treatment of abrupt closure of the angioplasty 
site (23). The balloon-expandable stent also offers a rapid 
percutaneous technique to permanently hold the intimal- 
medial flap against the vessel wall without the use of surgery, 
and avoids the extra catheterization laboratory equipment 
necessary for thermal angioplasty. 
Thermrrl Nngioplnsty including stents muy ulso be used ut 
the site oj’ahrrrpt closure in w1hic.h “spasm” is the culprit. 
Thermal injury to the segment of disease-free wall involved 
in spasm may permit long-term luminal distension. Hot- 
tipped lrrscrs can be used to reopen an angioplasty site 
occluded by thrombus with or without intimal flaps. (Fig. 
10~) (61-65). Atherectomy devices also can be used to 
remove large intimal-medial flaps. thrombus or both (Fig. 
IOe). 
Late (Chronic) Closure (“Rest~nosis”) 
Factors responsible for late restenosis. Despite the wide- 
spread acceptance and use of balloon angioplasty to treat 
severely narrowed coronary arteries in patients with symp- 
tomatic coronary heart disease, “recurrence of stenosis” 
(“restenosis”) at the angioplasty site within several months 
of the angioplasty procedure has been the major problem. 
The frequency of clinical restenosis ranges from 17% to 47%, 
depending on variations in definitions of restenosis (angio- 
graphic, clinical. anatomic, physiologic, statistical) (32,66- 
75). Multiple clinical-angiogruphic fuctors (number of ves- 
sels. site of angioplasty, pre- and postangioplasty diameter 
stenoses. transstenotic pressure gradients. lesion character- 
Figure 9. Diagram showing the use of 
a distal reperfusion balloon in the treat- 
ment of acute vessel closure after bal- 
loon angioplasty. 
Flaps held 
976 WALLER 
FUTURE TREATMENT OF CORONARY ARTERY DISEASE 
JACC Vol. 13, No. 5 
April 1989:969-87 
INTERVENTION VESSEL CHANGE 
a) Balloon Angioplasly 
b) Pyroplasty 
--) and potlion of 
c) Hot Tip 
ccps vessel 
d) Stent 
Portion of plaque 
e) Athrectomy 
Figure 10. Diagram showing the effects of various interventional 
devices used in the treatment of acutely or chronically obstructed 
coronary arteries. 
istics [diffuse, long, eccentric, calcified]), technical factors 
(number of inflations, duration of inflation, pressure of 
inflation, balloon-vessel size ratio, intimal flap or dissection, 
incomplete revascularization) and pharmacologic factors 
(anticoagulants, vasodilators) have been analyzed to deter- 
mine factors responsible for restenosis (72). Despite the 
large number of variables evaluated, studies diverge on the 
significance of many and concur on the significance of a few 
factors (72). 
Fibrocellular intimal proliferation (Fig. 4 and 7a). The 
most widely accepted theory for the development of the 
fibrocellular intimal proliferation lesion involves responses 
from damaged vessel endothelium and media. A major 
participant in the development of this fibrocellular response 
appears to be the smooth muscle cells of the media and 
diseased intima (plaque) (7,15,16,76). The most common 
mechanism of balloon ungioplusty (intimul-medial disrup- 
tion) is a likely initiating mechanism for restenosis. Mecha- 
nisms for the intimal fibrous proliferation may be precip- 
itated by the release of thromboxane A,, which leads to 
platelet deposition, release of platelet-derived growth factors 
(PDGF) and fibroblast and endothelial growth factors (76). 
This process results in migration, proliferation and alteration 
of the smooth muscle cells from the media, resulting in 
fibrocellular tissue accumulation. The fibrocellular 
“coating” narrows the vessel lumen. 
Other mechanisms of lute luminul narrowing at the 
ungioplusty site (“restenosis”) involve gradual elastic recoil 
of an overstretched disease-free wall of an eccentric lesion 
(Fig. 7b), return to predilation state of a stretched concentric 
lesion (Fig. 7c) and “progression of atherosclerotic plaque” 
(Fig. 7d). The latter mechanism appears unlikely in a short 
interval of 2 to 4 months after angioplasty. 
Treatment of chronic closure (“restenosis”). Treatment of 
restenosed lesions has primarily involved repeated balloon 
angioplasty procedures two, three and four times after the 
initial dilation (47,77). Various pharmacologic approaches to 
prevent restenosis using antiplatelet agents (aspirin, dipyri- 
damole) and calcium channel blockers have been used, but 
have been unsuccessful in reducing the frequency of resten- 
osis (72). Newer clinical trials with other antiplatelet agents 
(prostacyclin analogues, omega-3 fatty acids), steroids and 
platelet-derived growth factor blockers (78) are underway. 
Newer mechanical devices also may be used to delay or 
prevent intimal fibrous proliferation at the angioplasty site 
(Fig. 9 and IO). 
Balloon-expandable intravascular stems (Fig. 10d) have 
been proposed as an alternative approach to prevent resten- 
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Figure 11. Composite of consecutive 
histologic cross sections of the left main 
(LM I .2 [top left and top middle]) and left 
anterior descending (LAD 1,2,3.4,5 [top 
right and bottom]) coronary arteries 123 
days after successful balloon angioplasty 
of the proximal left anterior descending 
artery. The site of previous angioplasty 
(LAD 1,2,3) shows initial underlying ath- 
erosclerotic plaque (AP) with plaque 
“fracture” or “cracks” (C) (arrowheads) 
and localized medial dissection. Plaque 
channels created by the previous angio- 
plasty are filled with fibrocellular (FC) 
tissue that also extends over the denuded 
media and narrows the coronary lumen 
(L) 96% to 100% in cross-sectional area 
(LAD I ,2,3). The fibrocellular prolifera- 
tion is histologically distinct from the 
underlying plaque. Two segments of the 
left main artery (LM 1,2) show initial 
(old) atherosclerotic plaque narrowing 
the lumen 51% to 75% in cross-sectional 
area, with superimposed (new) fibrocel- 
lular tissue (FC) (arrows) increasing the 
luminal cross-sectional area to 76% to 
100%. The composition of the fibrocel- 
lular tissue in the left main artery is 
identical to that in the proximal left an- 
terior descending artery. (Elastic stains: 
original magnification x4. reduced by 
30%). From Waller et al. (17). 
osis (23.54). The mechanism of restenosis prevention with 
stents has not been established, but damage of smooth 
muscle cells of the vessel media or a purely mechanical 
effect of the stent. or both, is a possible explanation. 
Thermul angioplasr~ (Fig. lob) may alter the vessel media to 
prevent or at least delay the smooth muscle response in the 
development of intimal fibrous hyperplasia. Prolonged influ- 
tion time (30 to 60 min) with perfusion catheters is also being 
evaluated as a means of preventing restenosis (Fig. 9). 
Mechanical removal of the intimal fibrous hyperplasia mate- 
rial by atherectomy devices is also a method currently being 
evaluated (Fig. IOe). Simpson et al. (79.80) indicated that if 
all angiographically visible atheromas are removed. the rate 
of restenosis is as low as 14%. 
Effects of balloon angioplasty on adjacent nondilated ves- 
sels. Recent angiographic reports (81,82) have noted accel- 
erated development of coronary artery stenoses p~o.ui~~rrl to 
the site qfpreviou.s dilrrtion. In these reports, four patients 
underwent proximal left anterior descending coronary angio- 
plasty and returned 6 to 14 months later with a severe left 
main coronary artery lesion. Morphologic evaluation of 
these lesions was not available. Recently, we (16) reported 
histologic observations in an accelerated stenosis occurring 
proximal to a previously dilated lesion. The patient had 
balloon angioplasty of the proximal left anterior descending 
artery 4 months before returning with severe left main 
stenosis. At necropsy. two 5 mm long segments of the 
left main coronary artery disclosed initial (old) atheroscle- 
rotic plaque narrowing the lumen 51% to 75% in cross- 
sectional area, with superimposed (neri*) fibrocellular mate- 
rial further narrowing the cross-sectional luminal area to 
77% to 100%. The left main fibrocellular tissue NYU histolog- 
iu~lly identicrrl to thut oh.ser\Bed in thr prorimrrl left rrnterior 
deswndiy urtcy rrt thr site of‘pw~~ious balloon angioplasty 
(Fig. II). 
Accelcrrrtio~l of’ left main coronrrry cwtrr;v nriwoning by 
,fihroce/lu/w tis.s~~ prolijerution may have resulted from 
several possible mechanisms involving intimal injury 
(guiding catheter injury. guide wire injury. dilating balloon 
injury. combinations of these injuries) or retrograde exten- 
sion of the fibrocellular tissue from an adjacent site without 
left main arterial wail injury. The incidence of progressive 
left main coronary artery narrowing after angioplasty of the 
left anterior descending or left circumflex artery, or both, is 
unknown. but is probably low. Of more than 344 patients 
restudied angiographically within I year of previous coro- 
nary dilation in whom specific rrttcjntion was given to the 
left main coronary artery, only 4 patients (I%) were 
978 WAILER 
FUTURE TREATMENT OF CORONARY ARTERY DISEASE 
JACC Vol. 13, No. 5 
April 1989:96%87 
recognized with accelerated left main coronary artery nar- 
rowing (81,82). 
Balloon Pyroplasty (Thermal Balloon Angioplasty, 
“Biologic Stenting”) 
Thermal balloon angioplasty (Fig. lob), initially devel- 
oped as laser balloon angioplasty (83,84), is another method 
of “remolding” or remodeling a stenotic atherosclerotic 
vessel to increase luminal area. Thermal balloon angioplasty 
can use various energy sources (laser, radiofrequency, 
chemical, ultrasound) to produce a thermal injury on adja- 
cent plaque. Laser balloon angioplasty features traditional 
balloon angioplasty followed by laser irradiation of the 
atherosclerotic plaque-lined artery during a final balloon 
dilation (20,83). In one model, Nd:YAG laser energy fires 
through an ultrathin central fiber and is transmitted through 
the balloon and enters the adjacent plaque as heat. Animal 
(84,85) and cadaver (86,87) studies have indicated that 
thermal balloon angioplasty decreases vessel elasticity at the 
dilation site and heat “molds” the arterial segment to the 
size and shape of the inflated angioplasty balloon (Fig. 12). 
This process essentially creates a “biologic stent.” In addi- 
tion to the acute effects of remolding, thermal effects on the 
underlying media may destroy smooth muscle cells involved 
in the late restenosis process. 
Lee et al. (87) recently evaluated radiofrequency as an 
alternate energy source for balloon pyroplasty. Delivery of 
radiofrequency in combination with angioplasty balloon in- 
flation pressure effectively molded atherosclerotic plaque 
and vessels. Experimental studies on layers of human ca- 
daver aorta showed tissue fusion (“welding”) of previously 
separated layers, thus indicating its usefulness in the therapy 
of intraluminal intimal flaps (Fig. 13). Balloon pyroplasty has 
not been associated with subsequent vessel aneurysm or 
Figure 12. Specimen and diagrams 
showing the beneficial effects of ther- 
mal angioplasty (pyroplasty) on eccen- 
tric atherosclerotic plaques. A, Eccen- 
tric atherosclerotic vessel with a 
segment of disease-free wall (*) 
“molded” to the size and shape of an 
inflated balloon, followed by radiofre- 
quency pyroplasty. B, Same vessel 
showing an increase in luminal area 
(arrows) above expected nondilated lu- 
men (dashed lines). C, Eccentric plaque 
dilated without pyroplasty. Both ves- 
sels were dilated in the fresh state, then 
fixed in formalin. The vessel treated by 
thermal angioplasty remains in the 
stretched state (A, B), whereas the 
vessel dilated by angioplasty alone 
shrinks with formalin fixation (C). 
From Lee et al. (87), with permission. 
rupture in the experimental model. Thermal angioplasty with 
lower power, homogeneous heating and simultaneous tissue 
compression may be better than thermal probes (“hot-tipped 
probes”) that use an instantaneous high heat application to 
the luminal surface (Fig. 10~). 
Thermal probes (“G-lazing”). Coronary balloon angio- 
plasty may be followed by a laser thermal probe in an 
attempt to seal off superficial intimal disruptions (Fig. 10~). 
The low-powered probe skims through the treated vessel, 
“glazing” the new lumen. No removal of tissue results, but 
a “finishing touch” type of remodeling occurs (88). 
Stents. Placement of balloon-expandable intravascular 
stents has shown some promise in preventing abrupt closure 
and restenosis of atherosclerotic vessels (Fig. lOd, 12 and 
14). The woven wire stent expands at the target site and 
becomes permanently embedded within the arterial wall. 
After stent implantation, Serruys et al. (54) found an addi- 
Figure 13. Experimental studies on layers of human cadaver aorta 
by radiofrequency thermoplasty show tissue fusion (“welding”) 
(arrow) of previously separated layers. These results indicate the 
potential use of thermal angioplasty techniques to “weld” intralu- 
minal flaps from balloon angioplasty. 
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tional increase in cross-sectional area of the previously 
dilated vessel. Thus, the self-expanding metal meshwork 
appears to have a “stenting” and an additional “dilating” 
function. Histologic studies (23.54-60) of implanted stents in 
animals indicate that a neointimal layer covers the luminal 
aspect of the stent (Fig. IS). Stents appear to reduce luminal 
obstruction by displacing plaque, stretching vessel walls and 
maintaining intimal-medial flaps against adjacent vessel wall. 
Long-term effects of stents on the frequency of balloon 
angioplasty restenosis are under study. An initial report (80) 
suggests a marked reduction in the rate of angioplasty 
restenosis when a stenting device is used. 
Removal Techniques 
Various techniques and devices have been developed to 
alter the degree of luminal obstruction by removul of oh- 
strutting tissue (“scraping or shaving,” “drilling.” 
“burning” and “melting”). 
Laser Therapy 
The capacity to conduct tremendous amounts of energy 
and focus this energy onto a relatively small area of tissue 
has made laser devices combined with fiberoptic catheters 
an intriguing way to ablate atherosclerotic plaque. Laser 
light can be delivered as a continuous beam or as a pulse. 
Histologic studies of vascular tissue after continuous wave 
laser therapy show a cone-shaped crater surrounded by 
concentric zones of protein denaturation and tissue vacuoli- 
zation (65). The resulting charred, ragged endothelial surface 
is not desirable because it leads to thrombosis, and thermal 
diffusion leads to vessel perforation (65). Laser research has 
Figure 14. Intravascular stents in an experimental model. A, Double 
(tandem) Palmaz ctents easily visible radiographically (arrows). B, 
Postmortem radiograph of expanded stents located within the vessel 
seen in A. C, Stents can also be recognized with ultrasound 
(arrows). (Courtei;y of Dr. Gary Becker. Indiana University.) 
now concentrated on ablating tissue by limiting thermal 
injury. Two methods have attempted to achieve this goal: 1) 
mdiJ’urtion of the tip elf the deli~~ery .sJstetn of continuous 
wm’e lm.se~~.s, and 2) 11sfj of pulsed iu.~ers. 
Hot-tip probes. Sanborn (64) recanalized totally occluded 
peripheral arteries in human patients using a hot tip probe 
coupled to a continuous wave argon laser (Fig. 10~). Abela et 
al. (89) used a “hybrid hot tip” system to heat a metal cap 
and deliver laser energy through the center of the catheter. 
Histologic sections of vessels subjected to hot tip probes 
show thermally damaged plaque and media. Fouvier et al. 
(90) coupled a Nd:YAG laser to a sapphire tip. which 
diffuses the laser beam over a larger area than that reached 
by the bare wire (91). Advantages of the hot tip probe 
include its quickness of action, the creation of a large orifice 
and a possible reduction in the frequency of vessel petfora- 
tion. Disadvantages include limitations to its use in small 
vessels and an associated increased frequency of induction 
of spasm and thrombosis (65). Radiofrequency energy is an 
alternative power source for thermal probes and has the 
advantage of being considerably cheaper 120). 
Pulsed lasers. Pulsing the laser energy reduces the ther- 
mal damage by limiting thermal diffusion (65). Ultraviolet 
excimer laser light can be transmitted through a fiberoptic 
bundle with enough pulsed energy to ablate atheroma with- 
out a thermal effect. Tissue ablation occurs as a discrete 
precise event. The mechanism of ablation appears to be 
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Figure 15. Excised vascular stents. A, Three excised stents show- 
ing progressive fibrosis with advancing age (left to right). B and C, 
Histologic studies of peripheral vessel after removal of stent wires 
(S), showing fibrous hyperplasia (LFH) covering the luminal (L) 
surface of the stent. Hematoxylin eosin stains; original magnifica- 
tion x200, reduced by 28%. 
disruption of molecular bonds, and no thermal injury occurs 
because of a very rapid, highly localized heat effect (65). 
Thus, although it is hypothesized that removing atheroscle- 
rotic plaque by laser vaporization may be more effective 
than balloon angioplasty, the technique has been limited to 
date by inadequate delivery systems, a high frequency of 
vessel perforation and thrombosis and the creation of small 
recanalized channels. Newer systems employing fluores- 
cence spectroscopy will make use of tissue recognition 
before laser treatment. These “smart” lasers appear to 
reduce the frequency of vessel perforation. 
Atherectomy Devices 
Cutting instruments have been developed that can incise 
obstructing material (Fig. 10e and 16). A prototype of these 
devices is the Simpson atherotome, which consists of a 
circular blade rotating at a high speed and which is pressed 
Figure 16. Four fragments of human coronary artery atherosclerotic 
plaque, including portions of vessel media removed by an atherec- 
tomy catheter. 
against the diseased part of the vessel by an inflated balloon 
(79,80,91), The procedure can be repeated several times to 
remove atherosclerotic plaque, thrombus or intimal fibrous 
hyperplasia of restenosis lesions (79,80). Focal stenoses or 
short segment total occlusions and ulcerative and calcified 
lesions can be treated (Fig. 16). Atherectomy is an exciting 
new mechanical technique used in treating restenosis lesions 
of previous balloon angioplasty. Histologically, samples of 
atherosclerotic plaque removed from obstructed coronary 
arteries show portions of vessel media. Exposure of large 
segments of medial smooth muscle may predispose atherec- 
tomy sites to a frequency of intimal fibrous proliferation 
similar to or higher than that seen with conventional balloon 
angioplasty. Other atherectomy devices include the Kinsey 
catheter, Ritchie rotablater, transluminal extraction catheter 
and the Wholey reperfusion guidewire. 
New Concepts in Atherosclerotic Plaques: 
Plaque Fissures and Eccentric Lesions 
Two new areas in the pathology of atherosclerotic plaque 
include the concepts of plaqlre jssure and the eccentric 
atherosclerotic lesion. Both concepts will have a major 
impact on the future pharmacologic and mechanical therapy 
of patients with coronary artery disease. 
Plaque Fissure 
The missing link between anatomy, unstable angina pec- 
toris, acute myocardial infarction and sudden coronary death. 
Disruptions of the atherosclerotic plaque luminal surface 
have been termed “intimal tears,” “surface ulcerations,” 
“plaque ruptures” and, most recently, “plaque fissures” 
(Fig. 17) (92-97). The cause of the disruption is not com- 
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Figure 17. Diagram summarizing the clinical and 
morphoiogic consequences of atherosclerotic 
plaque fissures in patients with coronary heart 
disease. Modified from Davies and Thomas f96), 
with permission. 
Pathology Result 
Healed fissure, 
incorporated thrombus -._...__) 
Plaque growth --- 
Nonocclusive thrombus 
luminal (occlusive) -_) 
thrombus 
Occlusive thrombus 
Possible Clinical 
Consequences 
Progression of 
disease: onset or 
worsening of 
angina pectoris 
Unstable angina 
pectoris. acute 
myocardial 
infarction 
Acute myocardial in- 
farction, unstable 
angina pectoris 
pletely understood, but clinical and homodynamic factors 
such as systemic hypertension, smoking, blood lipids and 
luminai flow characteristics have been implicated. The role 
of plaque fissuring in the formation of thrombi found in 
association with fatal acute myocardial infarction is well 
known (93,94). Pathologic studies (92-97), in which coronary 
artery thrombi found in cases of fatal acute myocardial 
infarction were reconstructed from serial histologic sections, 
have shown that nearly all coronary thrombi were related to 
fissures of the underlying atherosclerotic plaque. Rupture of 
plaque leads to communication between the lipid content of 
the plaque and luminal blood products. Fibrin-platelet 
thrombus covers the fissure site and may or may not 
propagate (Fig. 17). A recent pathologic study (92) found 
similar plaque fissures and luminal thrombus in 74% of 
victims of sudden coronary death. More recent angio- 
graphic-histologic information (98-103) suggests that plaque 
fissures also occur frequently in patients with unstable 
angina pectoris. 
The eccentric coronary lesion with fissuring and thrombus. 
Coronary artery stenoses characterized by a narrow neck 
and irregular borders (“type 2 eccentric lesions” [98-1001, 
“T lesion” [loll) were the most common morphologic 
feature on angiograms from patients with unstable angina 
pectoris and acute myocardial infarction. The predominance 
of this angiographic lesion in both unstable angina pectoris 
and acute myocardial infarction suggests a link between 
these two conditions. Levin and Fallon (102) reported a 
valuable study in which postmortem angiography and sub- 
sequent histologic sections correlated the irregular luminal 
borders seen angiographically with histologically “compli- 
cated plaques” containing plaque fissures and superimposed 
STABLE ANGINA 
Stable atherosclerotic 
DIalwe 
Plaque 
healing 
Partial 
Plaque tissue 
(plaque ulcerating) 
Figure 18. Diagram showing that the 
plaque jkwre represents the “connecting 
link” to various clinical syndromes in ath- 
erosclerotic coronary heart disease. Mod- 
ified from Forrester et al. (103). with per- 
mission. 
l”romDolysls 
Progression of 
luminal plaque 
t 
I 
Progression of 
luminal narrowing 
MYOCARDIAL 
I Incorporation ot 
thrombus 1 
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partially occluding thrombus. In contrast, the angiographic 
coronary stenoses with smooth borders were associated with 
histologically “uncomplicated plaques” having intact in- 
timal surfaces and no thrombus. Thus, fissure of the athero- 
sclerotic plaque with thrombus formation appears to be the 
“missing link” connecting the acute clinical coronary syn- 
dromes of unstable angina pectoris, acute myocardial infarc- 
tion and sudden coronary death (Fig. 18). Several investiga- 
tors (103-105) recently confirmed these angiographic and 
Figure 20. Composite of six coronary artery cross sections of the 
eccentric form of luminal (L) narrowing by atherosclerotic plaque. 
Hematoxylin eosin stains: original magnification x IO to 12, reduced 
by 28%. From Wailer (39, with permission. 
Figure 19. Cross sections of human cor- 
onary arteries showing the concentric 
form of luminal (L) narrowing by athero- 
sclerotic plaque. Hematoxylin eosin 
stains; original magnification X 11, re- 
duced by 25%. 
necropsy observations in a series of patients undergoing 
coronary angioscopy. These authors expanded the concept 
of plaque fissure to the clinical syndromes of stable angina 
pectoris and accelerated angina pectoris (103). The distin- 
guishing feature among patients with stable angina pectoris 
and those with accelerated angina or unstable angina pec- 
toris appears to be the presence of the fissured plaques in the 
latter two groups. These findings have been used in support 
of thrombolytic and antithrombotic therapy in patients with 
unstable angina pectoris (106). 
Therapeutic implications. The frequent observation of 
plaque fissures in various coronary syndromes has potential 
major importance for future treatment programs. Interven- 
tions that prevent ulceration or plaque jissures, inhibit 
platelet-fibrin aggregation, lyse superimposed thrombus and 
promote endothelial healing will be needed to interrupt these 
clinical events (103). Pharmacologic or mechanical interven- 
tions, or both, can inhibit platelet-fibrin aggregation and lyse 
thrombus, but as yet no interventions are available to 
promote endothelial healing and prevent plaque fissures 
(103). 
Eccentric Atherosclerotic Plaques 
A connecting link between angioplasty restenosis, coronary 
spasm and angiographic underestimation of disease severity. 
Variation in the distribution of atherosclerotic plaque along 
the internal elastic membrane of human coronary arteries 
results in two major types of cross-sectional luminal shapes: 
concentric and eccentric (Fig. 19 to 21). If the atheroscle- 
rotic plaque is distributed along the entire circumference of 
the internal elastic membrane, the resulting vessel lumen is 
located centrally and is called a central or concentric type 
lumen (36) (Fig. 20). If the atherosclerotic plaque fails to 
involve the entire coronary artery circumference, leaving a 
variable arc of disease-free wall (normal wall), the residual 
cross-sectional lumen is called eccentric (36) (Fig. 21). The 
eccentric lumen has been further subdivided into slitlike, 
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Figure 21. Diagram comparing the thickness and struc- 
ture of coronary artery media (M) in the concentric and 
eccentric types of atherosclerotic plaque. A = adventi- 
tia. I = intima. From Wailer (35), with permission. 
Media is normal 
and vasoactive 
polymorphous or semilunar types (36,37). Although the 
polymorphous type of eccentric lumen may be observed 
with variable degrees of obstruction, the slitlike eccentric 
lumen is always associated with severe (>75%) cross- 
sectional area narrowing (33). 
Frequency. The frequency of concentric and eccentric 
type lesions has been evaluated by several investigators (33- 
37). On the basis of examination of 200 atherosclerotic 
coronary artery sections, Vlodaver and Edwards (36) ob- 
served an eccentric (that is, eccentric polymorphous and 
eccentric slitlike) coronary lumen in 70% of cross sections 
examined and a concentric coronary lumen in the remaining 
30% of sections. Baroldi (37) examined 1,069 sites of severe 
(>70%) diameter reduction and found that 46% of the 
coronary lumen shapes were concentric, 24% eccentric 
(lateral lumen position but still encircled by plaque) and 30% 
“semilunar” (a variable arc of disease-free wall). We (35) 
reported histologic observations in 500 coronary artery 
segments narrowed 76% to 95% in cross-sectional area by 
atherosclerotic plaque. Of the 500 segments, 365 (73%) were 
eccentric and 135 (27%) were concentric. The portion of 
vessel circumference in the eccentric lesion that is free of 
disease varies from 17% to 23% (mean 20%) (33) and from 
2.3% to 32% (mean 17%) (35). We (35) also compared the 
thickness of the coronary medial layer in diseased and 
disease-free portions of the coronary artery segments (Fig. 
21). The average thickness of the coronary artery media was 
rhinner in diseased segments (mean 99.4 pm) compared with 
disease-free wall segments in the same vessel (mean 202.9 
pm). 
Role of eccentric plaque in coronary angioplasty and 
restenosis. Recent interest in eccentric coronary plaque has 
connected this lesion to mechanisms of coronary artery 
angioplasty and restenosis (34,3.5), coronary artery spasm 
(33,35) and angiographic underestimation of severity of 
coronary atherosclerosis (Fig. 20) (34,35,107). 
As described earlier, sfretching of the plaque-free wall in 
eccentric atherosclerotic lesions is one of the mechanisms of 
coronary balloon angioplasty (Fig. 5). Morphologic data 
indicating the high degree of frequency of the eccentric 
lesion in patients with clinical coronary heart disease sug- 
gests that stretching of the plaque-free wall may be a more 
frequent mechanism than previously thought (35). In addi- 
tion, dilation of the disease-free arc without damage to 
plaque on the opposite walls may provide an explanation for 
ear/~~ (Fig. 6b and 22) and late (Fig. 7b and 22) “restenosis” 
after an angiographically successful dilation. Initial stretch- 
ing of the plaque-free segment may gradually “relax” (“res- 
titution of tone”) and decrease the coronary lumen toward 
its predilation state (“restenosis”). Thermal angioplasty 
may prove to be an effective way of preventing this elastic 
recoil of the eccentric lesion (Fig. 12). 
Role of eccentric plaque and coronary spasm. In addition 
to stretching. the disease-free wall of the eccentric plaque 
may be susceptible to spasm. The normal or nearly normal 
arc of coronary wall (normal medial thickness) is capable of 
“reacting” to various humoral or neurogenic stimuli (Fig. 
22). The extent to which dynamic augmentation or contrac- 
tion of the coronary wall (that is, spasm) is possible appears 
to be a function of the amount and location of the wall 
smooth muscle. The potential for dynamic alterations of the 
coronary lumen (spasm) is less likely to occur along the 
diseased circumference, but more likely to occur along the 
disease-free segment of an eccentric coronary lesion. Ther- 
mal angioplasty also may be useful in preventing spasm of 
eccentric plaque by producing injury to the medial smooth 
muscle cell (Fig. 12) (87). 
Role in interpreting coronary angiograms. A third role of 
eccentric plaque occurs in interpreting coronary angiograms. 
Several necropsy studies (107) indicated some degree of 
undrrestimckm of the angiographic assessment of coronary 
stenosis severity. Variability in coronary lumen shape rep- 
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/ 
resents one explanation for this underestimation. The eccen- 
tric plaque, and in particular, the slitlike lumen (Fig. 20), is 
most likely to pose a problem for the angiographic assess- 
ment of disease. Because the length of the luminal slit 
approaches the full dimension of the original luminal diam- 
eter, the angiographic appearance will be that of a “normal” 
vessel. The luminal reduction in cross-sectional area is, 
however, >75%. 
Diagnosis. The current development of intravascular 
ultrasound imaging catheters will aid in the detection of the 
eccentric coronary lesion. These devices generate highly 
accurate cross-sectional pictures of the arterial wall showing 
its three-layered structure and wall composition (Fig. 23). 
From the ultrasound image, it is possible to determine the 
presence or absence of atherosclerotic plaque or thrombus, 
or both, determine the integrity of the luminal surface (that 
is, detect plaque fissures) and determine the location, size, 
type (that is, concentric versus eccentric) and composition 
(that is, fatty versus fibrous, calcified versus noncalcified) of 
atherosclerotic plaque (108,109). This new intravascular 
device represents an exciting and promising potential for 
visualization of the coronary artery and assessing the results 
of various new interventional techniques. 
Conclusion 
Although various public health preventive efforts and 
prescribed pharmacologic methods will have long-term ben- 
efits in the reduction of coronary artery atherosclerosis and 
Figure 22. Diagram showing the clinical relevance 
(angioplasty, spasm, angiography) of eccentric athero- 
sclerotic plaque in patients with coronary artery dis- 
ease. 
subsequent cardiac events, the immediate and short-term 
future in the treatment of coronary artery disease will be 
focused on various interventional devices designed to re- 
model or remove the causes of acute and chronic coronary 
artery occlusion. 
I acknowledge the artistic talents of George Buckley and the secretarial 
assistance of Marcy Gulp. 
Figure 23. Photograph of an in vitro ultrasound image of a diseased 
human coronary artery, showing the coronary lumen (L), athero- 
sclerotic intima (AP), echo-free media (M) and adventitia (A). 
(Courtesy of Paul Zalesky, Intertherapy, Inc.) 
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